Biosafety Testing Laboratory project
Key Statistics
PM Group Office
$20 million SGD
3,800 Sq.m

In Singapore, Merck opened its first GMP BioReliance® biosafety testing lab in Asia Pacific, offering critical testing services to bring life-changing therapies to market.

A first for Asia

PM Group's Singapore team provided full EPCMCQ services on the 3,800 sqm complex. It features an extensive range of upstream and downstream bioprocessing solutions and media development services.

The lab was the first of its kind outside of the US and UK, and a first for Singapore and Asia.

The challenge

"Co-locating multiple business units and technologies into one collaborative space was both a technical and functional challenge. But with a cohesive team and a strong partnership with the Merck stakeholders, it has proved to be recipe for success.” Said David Monaghan,  Operations Manager, PM Group - Singapore.

This 20 million SGD investment marked Merck’s commitment to a strong presence in Singapore as a key biotech hub for Asia.